Inventor
SUN DONGXU
CN24 patents
⚠️ This page may combine multiple inventors who share the name “SUN DONGXU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ICONIX PHARM INC
7 patentsUS7053216B2May 30, 2006
Modulators of Rho C activity
ICONIX PHARM INC29 citations91
US6642263B2Nov 4, 2003
Modulators of Rho C activity
ICONIX PHARM INC13 citations82
US6800634B2Oct 5, 2004
Modulators of Rho C activity
ICONIX PHARM INC7 citations72
US7049468B2May 23, 2006
Modulators of Rho C activity
ICONIX PHARM INC6 citations61
US6908932B2Jun 21, 2005
Modulators of phosphoinositide 3-kinase
ICONIX PHARM INC5 citations57
US6894055B2May 17, 2005
Thieno-2′,3′ -5,6pyrimido[3,4-A]-1,2,4-triazole derivatives as modulators of phoshoinositide 3-kinase
ICONIX PHARM INC4 citations57
US6537996B2Mar 25, 2003
Modulators of p38 MAP kinase
ICONIX PHARM INC0 citations48
MICROCIDE PHARMACEUTICALS INC
4 patentsUS6228588B1May 8, 2001
Methods of screening for compounds active on Staphylococcus aureus target genes
MICROCIDE PHARMACEUTICALS INC30 citations95
US6037123AMar 14, 2000
Methods of screening for compounds active on Staphylococcus aureus target genes
MICROCIDE PHARMACEUTICALS INC45 citations95
US6187541B1Feb 13, 2001
Methods of screening for compounds active on staphylococcus aureus target genes
MICROCIDE PHARMACEUTICALS INC18 citations91
US5962249AOct 5, 1999
Sized-based marker identification technology
MICROCIDE PHARMACEUTICALS INC6 citations61
TRUEBINDING INC
4 patentsUS11427638B2Aug 30, 2022
Anti-Gal3 antibodies and uses thereof
TRUEBINDING INC5 citations79
US12227567B2Feb 18, 2025
Treating cancer by blocking the interaction of TIM-3 and its ligand
TRUEBINDING INC2 citations73
US12497458B2Dec 16, 2025
Anti-GAL3 antibodies and uses thereof
TRUEBINDING INC1 citations60
US12281166B2Apr 22, 2025
Methods of treating inflammatory diseases by blocking Galectin-3
TRUEBINDING INC1 citations53
ESSENTIAL THERAPEUTICS INC
3 patentsUS6638718B1Oct 28, 2003
Methods of screening for compounds active on staphylococcus aureus target genes
ESSENTIAL THERAPEUTICS INC8 citations72
US6630303B1Oct 7, 2003
Methods of screening for compounds active on Staphylococcus aureus target genes
ESSENTIAL THERAPEUTICS INC8 citations72
US6514746B1Feb 4, 2003
Staphylococcus aureus histidine protein kinase essential genes
ESSENTIAL THERAPEUTICS INC0 citations50